TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Alcidion Group Limited ( (AU:ALC) ) just unveiled an update.
Alcidion Group Limited announced the withdrawal of ‘Resolution 3 – Approval of 10% Placement Facility’ from its upcoming Annual General Meeting agenda. This decision follows shareholder feedback and the company’s current lack of intention to use the additional placement capacity. The withdrawal does not affect the validity of proxy votes for other resolutions, which will proceed as planned. This move reflects Alcidion’s responsiveness to shareholder input and its current strategic focus, potentially impacting its capital management strategies.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions aimed at improving patient care efficiency and quality. Their flagship product, Miya Precision, supports healthcare organizations by aggregating information, facilitating communication, and providing clinical decision support. Alcidion has expanded its operations to over 400 hospitals and 87 healthcare organizations across the UK, Australia, and New Zealand, with plans for further geographical expansion.
Average Trading Volume: 912,064
Technical Sentiment Signal: Buy
Current Market Cap: A$128.9M
Learn more about ALC stock on TipRanks’ Stock Analysis page.